← ANALYST RATINGS · TIPRANKS

Evolent Health (EVH): analyst forecast and price target

$4.57 −6.16% close 16.10.26 · market cap $551M · Healthcare · Medical - Healthcare Information Services IWM 0.02%
Price targets and ratings of

Analyst consensus

Moderate Buy

8 Buy3 Hold0 Sell

Ratings of 11 analysts in the last 3 months

12-month forecast

$5.56+21.6% upside

Based on 11 price targets given in the last 3 months, the average target is $5.56, the highest $6.00, the lowest $3.00. The average is +21.6% from the last price of $4.57.

$2.00$4.00$6.00$8.00Jan 26AprJulOctJan 27AprJulOctHigh$6.00Average$5.56Low$3.00
Highest target $6.00 Average target $5.56 Lowest target $3.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Ryan Halsted★★★★★★★★★★#3317 · hits 60% · avg +9.0% RBC Capital $3.00 Hold −34.4% Reiterated 06.10.26on TipRanks 21:45 +8.1%next day −3.9% · 5 days +15.2%
John Stansel★★★★★★★★★★#9374 · hits 46% · avg −2.3% J.P. Morgan $5.00 → $6.00+20.0% Buy +31.3% Assigned 18.08.26on TipRanks 07:20 +4.5%next day −0.2% · 5 days +7.0%
Charles Rhyee★★★★★★★★★★#1937 · hits 54% · avg +5.6% TD Cowen $5.00 → $6.00+20.0% Buy +31.3% Assigned 17.08.26on TipRanks Aug 16 22:30 −5.3%next day +4.5% · 5 days +8.2%
Jailendra Singh★★★★★★★★★★#12131 · hits 43% · avg −6.4% Truist Financial $7.00 → $6.00−14.3% Hold +31.3% Assigned 12.08.26on TipRanks 07:35 +1.5%next day +11.1% · 5 days +10.3%
Daniel Grosslight★★★★★★★★★★#4007 · hits 47% · avg +3.6% Citi $6.75 → $6.00−11.1% Buy +31.3% Upgrade 11.08.26on TipRanks Aug 10 16:15 +4.6%next day +1.5% · 5 days +12.1%
Richard Close★★★★★★★★★★#1081 · hits 49% · avg +10.0% Canaccord Genuity $7.00 → $6.00−14.3% Buy +31.3% Reiterated 10.08.26on TipRanks 07:20 −0.5%next day +4.6% · 5 days +12.3%
Matthew Gillmor CFA★★★★★★★★★★#6184 · hits 53% · avg +2.0% KeyBanc — Hold — Reiterated 10.08.26on TipRanks 03:55 −0.5%next day +4.6% · 5 days +12.3%
Michael Wiederhorn★★★★★★★★★★#535 · hits 59% · avg +11.3% Oppenheimer $6.00 Buy +31.3% Assigned 07.08.26on TipRanks 08:20 +9.4%next day −0.5% · 5 days +18.1%
Sean Dodge★★★★★★★★★★#11980 · hits 43% · avg −4.3% BMO Capital $6.00 Buy +31.3% Reiterated 06.08.26on TipRanks Aug 7 08:10 +16.7%next day +9.4% · 5 days +28.6%
Ryan Halsted★★★★★★★★★★#3317 · hits 60% · avg +9.0% RBC Capital $3.00 Hold −34.4% Reiterated 06.08.26on TipRanks Aug 7 07:06 +16.7%next day +9.4% · 5 days +28.6%
Matthew Shea★★★★★★★★★★#6280 · hits 52% · avg +3.4% Needham $5.00 Buy +9.4% Reiterated 06.08.26on TipRanks 17:36 +9.4%next day −0.5% · 5 days +18.1%
Ryan Daniels★★★★★★★★★★#2878 · hits 48% · avg +5.8% William Blair — Buy — Reiterated 06.08.26on TipRanks 13:35 +16.7%next day +9.4% · 5 days +28.6%
David Larsen★★★★★★★★★★#12072 · hits 35% · avg −4.7% BTIG $8.00 Buy +75.1% Assigned 16.07.26on TipRanks 06:50 −2.9%next day +3.5% · 5 days −16.5%
Kevin Caliendo★★★★★★★★★★#2646 · hits 56% · avg +5.6% UBS $5.00 Buy +9.4% Reiterated 08.05.26on TipRanks 06:40 −2.9%next day −5.5% · 5 days −5.5%
Jeffrey Garro★★★★★★★★★★#12266 · hits 30% · avg −24.4% Stephens $7.00 Buy +53.2% Reiterated 25.02.26on TipRanks Feb 26 09:45 +21.8%next day +6.3% · 5 days +14.2%
Constantine Davides★★★★★★★★★★#12158 · hits 36% · avg −12.7% Citizens JMP $11.00 → $10.00−9.1% Buy +118.8% Reiterated 06.01.26on TipRanks 05:45 +1.2%next day +3.6% · 5 days −0.5%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering Evolent Health

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Richard Close★★★★★★★★★★Canaccord Genuity · #1081
Hits 49%237 of 482 Average return +10.0%
1 year Richard Close★★★★★★★★★★Canaccord Genuity · #1081
Hits 49%237 of 482 Average return +10.0%
2 years Richard Close★★★★★★★★★★Canaccord Genuity · #1081
Hits 49%237 of 482 Average return +10.0%

Most profitable

3 months Richard Close★★★★★★★★★★Canaccord Genuity · #1081
Hits 49%237 of 482 Average return +10.0%
1 year Richard Close★★★★★★★★★★Canaccord Genuity · #1081
Hits 49%237 of 482 Average return +10.0%
2 years Richard Close★★★★★★★★★★Canaccord Genuity · #1081
Hits 49%237 of 482 Average return +10.0%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $5.80 at a price of $3.49 (+66.2%); now: $5.56 at $4.57 (+21.6%).

$4.00$5.00$6.00Sep 15Oct 1Oct 15Top analysts$5.20Average target$5.56Price$4.57

PriceAverage targetTop analysts’ target

Recommendation trend

01020156Oct 25205Nov164Dec1551Jan 26773Feb893Mar783Apr2113May194Jun1125Jul396Aug385Sep354Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy211333
Buy11912985
Hold345654
Sell000000

Earnings and sales forecast

Next report: 05.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $0.06 (from $0.01 to $0.10). Last quarter: $0.02.

Sales

Next quarter’s sales estimate — $727M (from $687M to $755M). Last quarter: $653M.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Evolent Health
  • CEO: Seth Barrie Blackley
  • Employees: 4,200
  • 1812 N. Moore Street, Arlington, VA, 22209, US
  • www.evolent.com

Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.

Data from the stock’s TipRanks forecast page, read 9 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗